BRUSSELS, July 19 — The European medicines regulator said today it was evaluating an application to use immunosuppressant drug Kineret to treat Covid-19 in adult patients with pneumonia who are at risk of developing severe respiratory failure. — Reuters
Advertisement
EU evaluates use of immunosuppressant to treat Covid-19 patients with pneumonia
Join us on our WhatsApp Channel, follow us on Instagram, and receive browser alerts for the latest news you need to know.
Monday, 19 Jul 2021 5:42 PM MYT
Advertisement
You May Also Like
Related Articles
Advertisement
Just IN
Advertisement